Collaborative Trajectory Analysis Project

To advance understanding of disease progression in duchenne muscular dystrophy by fostering collaboration among regulators, clinical experts, drug developers, and patient groups. The organization develops data-driven tools and insights to support drug development, shares findings broadly across the duchenne community, and works to accelerate clinical research and deliver improved therapies to patients sooner.